期刊
EUROPEAN NEUROPSYCHOPHARMACOLOGY
卷 13, 期 3, 页码 183-185出版社
ELSEVIER
DOI: 10.1016/S0924-977X(03)00006-3
关键词
pharmacogenetics; risperidone; polymorphism; dopamine; adolescence
This study examined the possible association between the polymorphism in the dopamine receptor DRD4 gene and response to risperidone among 24 Israeli Jewish adolescent inpatients with first-episode schizophrenia. Response was categorically determined by a change of >40% on the Brief Psychiatric Rating Scale (BPRS). No significant association was found between the DRD4 genotype and clinical response, although carriers of <7 repeat alleles demonstrated higher response rate (10/20 vs. 0/4, P=0.11). Studies in larger groups of adolescent schizophrenia patients are warranted to clarify the possible association between DRD4 exon III repeat alleles and the response to risperidone. (C) 2003 Elsevier Science B.V./ECNP All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据